Moxifloxacin as the likely cause of drug-induced linear immunoglobulin A bullous dermatosis.
Linear immunoglobulin A bullous dermatosis (LABD) is an immune-mediated subepidermal blistering disease that can be triggered by drug exposures, most notably, vancomycin. The authors report of a case of a 72-year-old man who developed LABD after a course of moxifloxacin. To the authors' knowledge, there is no other case of LABD caused by moxifloxacin in the medical literature.
Kovacic
Dianne
D
Department of Dermatology, University of Texas Medical Branch, Austin, TX 78701, USA.
Fox
Matthew
M
Reichenberg
Jason
J
D000368:Aged; D000900:Anti-Bacterial Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001372:Aza Compounds / Q000009:adverse effects* / Q000627:therapeutic use; D003875:Drug Eruptions / Q000276:immunology / Q000473:pathology*; D024841:Fluoroquinolones; D006801:Humans; D007070:Immunoglobulin A / Q000276:immunology*; D008297:Male; D000077266:Moxifloxacin; D011804:Quinolines / Q000009:adverse effects* / Q000627:therapeutic use; D012852:Sinusitis / Q000188:drug therapy / Q000473:pathology; D012867:Skin / Q000473:pathology; D012872:Skin Diseases, Vesiculobullous / Q000139:chemically induced* / Q000276:immunology / Q000473:pathology*
D000900:Anti-Bacterial Agents; D001372:Aza Compounds; D024841:Fluoroquinolones; D007070:Immunoglobulin A; D011804:Quinolines; D000077266:Moxifloxacin